Replies to post #6128 on IntelGenx Technologies Corp (IGXT)

[senderos]

They don't speak Russian.

[crookedneck]

From what I gather, IGXT was evaluating FORFIVO XL in Russia and the data was used in acheiving FDA approval Oct. 11th 2011. Thus the reason the company didn't make an announcement on it, as this was data collected prior to the approval date. See excerpt from article below:

Table 3. New drugs approved by FDA in Q4 2011 and tested in Russian sites
Appr.date Drug (active ingredient)
06/10/2011 Fluoxetine hydrochloridehydrochloride
07/10/2011 Combivent respimat Ipratropium bromide
04/11/2011 Xarelto (R09/11/2011 Levetiracetam in sodium chloride (Levetiracetam
10/11/2011 Forfivo XL
14/11/2011 Morphine sulfate
16/11/2011 Jakafi (Ruxolitinib phosphate Infectious deseases